“borderline significant”

The HR for Q2–4 combined as compared to Q1 was significant in the univariate analysis [1.42 (1.09–1.99), p = 0.046], but became borderline significant after adjusting for the variables in Model 3 [1.42 (1.00–2.04), p = 0.052], as shown in Table 4 .

However, AI at the most telomeric marker D11S2071 showed a borderline significant association with earlier relapse compared to patients not showing and AI around this locus (p = 0.052)( Figure S1 ).

Here, fibulin-2 expression showed a borderline significant association with RFS (p = 0.052; Table 4 ).

When comparing healthy individuals with immunosuppressed KTPs, the healthy group was younger (p < 0.001), had significantly higher QFM values (p = 0.001), and had lower TTVL, with a borderline significant statistical difference (p = 0.052) ( Figure 1 ).

However, a borderline significant increase was seen between markers 2 and 3 on the VD radiographic view (9.2 mm vs. 9.8 mm, p = 0.052) and between markers 3 and 4 on the lateral radiographic view (9.0 mm vs. 9.9 mm, p = 0.059).

In addition, we observed that higher white wine intake and higher olive oil intake were borderline significant associated with a more rapid decline of memory decline in women (model 2: −0.13; 95% CI: (−0.26, 0.001); P = 0.052, and −0.08; 95% CI: (−0.16, 0.01); P = 0.065, respectively).

aureus bacteremia, mortality was reduced, although this difference was only borderline significant ( P = 0.052), indicating a trend in improvement of survival rate in skin infected mice with subsequent endogenous bacteremia.

On the other hand, TROY expression was higher in the tumor-adjacent normal tissue of the distal stomach (3.5 ± 1.1) versus the proximal (2.7 ± 0.8) region, which was borderline significant ( p = 0.052, Table 3 ).

sCCA detected a borderline significant association ( p = .052) between “cluster 1” (which included both delusions of influence and grandiose delusions), and the same SNP rs11411529.

The effect of carbimazole was borderline significant compared to the control group ( p = 0.052), whereas the effect of L-thyroxine was highly significant ( p < 0.0001).

suis -positive pigs, which was borderline significant (68% vs 44%, p = 0.052).

Notably, in the VITACOG trial, aspirin use was also incidentally found to have a borderline significant negative interaction (P = 0.052) with B vitamins in slowing whole brain atrophy rate ( 7 ).

The mean difference in pre- and post-intervention scores was borderline significant, changing from 4.00±0.71 pre-intervention to 3.56±0.53 post-intervention (p=0.052) (Table 3 ).

Upon additional adjustment for BMI, the association with CHF was rendered nonsignificant, and the association with CVD was borderline significant ( P = 0.052).

Here, after adjustment for these and other factors, we found a borderline significant association ( p = 0.052) between greater number of comorbidities and increased risk of incident falls in men.

Furthermore, BAT volume was lower in South Asians as compared to white Caucasians (185 mL vs 303 mL), which was borderline significant (p = 0.052) while the difference was significant in the original study 25 due to larger sample size.

Stage of disease had a statistically significant impact on PFS (HR:0.338; CI95%:0.161–0.709, p value = 0.004), and a borderline significant impact on OS (HR:0.474; CI95%:0.224–1.006, p value = 0.052).

Similarly, SOX2 expression was higher in moderately differentiated OSCC patients (71%), but this too was borderline significant ( P =0.052). 3.6.

Interestingly, PTSD at wave 4 emerged as a significant predictor in the simple multinomial regression (odds ratio 18.78, 95% CI: 2.46–143.33, p = 0.005) and as a borderline significant predictor in the full model (odds ratio 8.04, 95% CI: 0.98–65.73, p = 0.052).

The log-rank test for equality of survival functions was significant for involvement of the cervix ( P = .0098) and borderline significant ( P = .0522) comparing adnexa and serosal involvement.

For tubulovillous crypt phenotypes the proportion of cases with UC‐PDG was borderline significant ( p = 0.0522) than in those with UC‐aspa.

In contrast, during March–May 2014 (n = 96), dominating emm types changed, with a borderline significant increase in emm 3 (from 10% in March–May 2009–2013 to 20% in 2014; χ 2 (1df) = 3.766, p = 0.0523), and a significant >5-fold increase in emm 4 (from 3% to 17%; χ 2 (1df) = 9.478, p = 0.0021).

For the discrimination of survivors from non-survivors PCT and creatinine clearance were borderline significant ( P = 0.0523 and P = 0.0539).

There was a significant difference between guaifenesin 1200 mg BID and placebo-1200 ( P =0.0211) for GATH and a borderline significant difference between these 2 groups for muscle relaxation ( P =0.0523).

Moreover, for the SKOV3 cell line, CXB treatment was borderline significant compared to its control ( p -value= 0.0524) ( Figure 9 B).